About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
HAE - Haemonetics Corporat...| Previous Close | $118.00 | Open | |
| Volume | Market Cap | 6.325B | |
| Yield | Last Dividend |
| Haemonetics snaps up Cardiva Medical for... | 01/20/21 |
| Haemonetics Corp. said Wednesday that it will acquire Cardiva Medical Inc., a privately held manufacturer of blood closure systems, for up to $510 mil... | |
| Needham Stick to Their Buy Rating for Ha... | 01/20/21 |
| Needham Stick to Their Buy Rating for Haemonetics Corp. | |
| Blood Management Devices Market Trends, ... | 01/16/21 |
| ReportsnReports.com the exclusive leading provider of market research reports published research report on ???Global Blood Management Devices Key Tren... | |
| Raymond James Stick to Their Buy Rating ... | 01/07/21 |
| Raymond James Stick to Their Buy Rating for Haemonetics Corp. | |
| US Therapeutic Plasma Exchange Market wo... | 01/07/21 |
| According to the new market research report "US Therapeutic Plasma Exchange Market" by Product (Devices, Consumables) Technology (Centrifugation, Memb... | |
| Apheresis Market 2020 Major Key Companie... | 12/09/20 |
| Market Scenario The global apheresis market is presumed to register 10.2 % CAGR during the forecast period (2017-2023), owing to the increasing preval... | |
| Global Therapeutic Plasma Exchange Marke... | 11/06/20 |
| InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on ???Global Therapeutic Plasma Exchange Market Assessment ??? Rev... | |
| Autotransfusion Device Market Is Project... | 11/06/20 |
| A new research document with title Global Autotransfusion Device Market Report covering detailed analysis, Competitive landscape, forecast and strateg... | |
| Haemonetics 2nd Quarter Fiscal Year 2021... | 11/04/20 |
| BOSTON, Nov. 4, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its second quarter fiscal 2021, which end... | |
| Apheresis Market Size To Reach USD 4.20 ... | 10/16/20 |
| UPDATE AVAILABLE ON-DEMAND According to the report by Allied Market Research, the global apheresis market is estimated to register a CAGR of 7.3% from... | |
| Haemonetics To Present At The 18th Annua... | 09/09/20 |
| BOSTON, Sept. 9, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 18th Annu... | |
| Haemonetics First Quarter Fiscal 2021 Ea... | 08/04/20 |
| BOSTON, Aug. 4, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter fiscal 2021, which ende... | |
| The Week Ahead In Biotech: Novavax Coron... | 08/02/20 |
| Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flo... | |
| High school staff make visors for new ca... | 06/22/20 |
| Face visors designed and made in a local high school are being donated for use in Liverpool???s first dedicated cancer hospital. The face visors, desi... | |
| HAEMATO : AGM postponement | MarketScree... | 05/27/20 |
| Due to the present imponderables HAEMATO AG will reschedule the Annual General Meeting originally intended on July 8, 2020 to a later date. Due to the... | |
| Haemonetics 4th Quarter and Fiscal 2020 ... | 05/05/20 |
| BOSTON, May 5, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its fourth quarter and fiscal 2020, which ... | |
| The Week Ahead In Biotech: Smid-Cap Earn... | 05/03/20 |
| Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma nam... | |
| The Daily Biotech Pulse: Pfizer's Eczema... | 03/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)... | |
| Haemonetics Announces Acquisition Of Int... | 01/14/20 |
| BOSTON, Jan. 14, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hemato... | |
| Haemonetics Sets Date for Publishing Thi... | 12/19/19 |
| BOSTON, Dec. 19, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2020... | |
| Said Bolorforosh Sells 339 Shares of Hae... | 11/16/19 |
| Haemonetics Co. (NYSE:HAE) EVP Said Bolorforosh sold 339 shares of the business???s stock in a transaction that occurred on Monday, November 11th. The... | |
| Haemonetics 2nd Quarter and First Half F... | 11/01/19 |
| BRAINTREE, Mass., Nov. 1, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter and first h... | |
| The Daily Biotech Pulse: Setback For Bri... | 07/25/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 24) ... | |
| Moving Average Crossover Alert: Haemonet... | 07/11/19 |
| Haemonetics Corporation (HAE) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the movin... | |
| Haemonetics Corporation (HAE) CEO Chris ... | 02/05/19 |
| No summary available. | |
| Buy rating | 01/20/21 |
| Needham maintains Buy rating and raises Price Target from $122.00 to $142.00 | |
| Strong Buy rating | 01/07/21 |
| Raymond James maintains Outperform rating and raises Price Target from $130.00 to $135.00 | |
| Strong Buy rating | 12/15/20 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $110.00 to $139.00 | |
| Strong Buy rating | 11/02/20 |
| Raymond James maintains Outperform rating and raises Price Target from $100.00 to $130.00 | |
| Date | 2020-11-04 (BMO) | Est. (EPS/Rev.) | $0.51/ 207.65M |
| Actual (EPS/Rev.) | $0.62/ $209.49 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Momentum Trading | j sal | 33.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
